Clinical Trial Update: A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function [NA]

View source ↗

Summary

An update on a randomized trial assessing intracoronary abciximab (ReoPro) to improve coronary microvascular function in patients with myocardial infarction and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• ReoPro (abciximab)

Snippet

Sponsor: University of Melbourne | Conditions: Myocardial Infarction, Coronary Artery Disease | NA | Status: UNKNOWN